0001773558-19-000001.txt : 20190415
0001773558-19-000001.hdr.sgml : 20190415
20190415103748
ACCESSION NUMBER: 0001773558-19-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20190415
DATE AS OF CHANGE: 20190415
EFFECTIVENESS DATE: 20190415
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaporox, Inc.
CENTRAL INDEX KEY: 0001773558
IRS NUMBER: 811586753
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-337269
FILM NUMBER: 19747811
BUSINESS ADDRESS:
STREET 1: 3513 BRIGHTON BOULEVARD, SUITE 435
CITY: DENVER
STATE: CO
ZIP: 80216
BUSINESS PHONE: 303-558-5145
MAIL ADDRESS:
STREET 1: 3513 BRIGHTON BOULEVARD, SUITE 435
CITY: DENVER
STATE: CO
ZIP: 80216
D
1
primary_doc.xml
X0708
D
LIVE
0001773558
Vaporox, Inc.
3513 Brighton Blvd, Suite 435
Denver
CO
COLORADO
80216
303-558-5145
DELAWARE
None
None
Corporation
true
Alan
Sage
1196 S. Lincoln St.
Denver
CO
COLORADO
80210
Executive Officer
Director
Promoter
Louis
Woodhill
2473 N. Field Street
Dallas
TX
TEXAS
75201
Director
Alex
Goldstein
1800 Ocean Drive
#2603
Hallandale Beach
FL
FLORIDA
33009
Director
Biotechnology
No Revenues
- 06b
false
2019-03-25
false
true
false
5485
not applicable
None
None
None
not applicable
not applicable
CO
COLORADO
80216
CO
COLORADO
false
Indefinite
470000
Indefinite
The total offering amount is undetermined at this point in time. The total amount sold to date is $470,000.
false
5
0
0
The corporation is not planning to pay any co sales commissions or finders' fees.
300000
Directors loaned the corporation $300,000 during the period of Jan - March, 2019 for working capital while the terms of the offering were being prepared.
false
Vaporox, Inc.
Alan Sage
Alan Sage
CEO/President
2019-04-15